Poster
Impact of Nirogacestat on Pain, a Key Symptom in Patients With Desmoid Tumors: Results From the Phase 3 DeFi Study
Author
Winette T.A. van der Graaf
Condition
Desmoid Tumors
Drug target
Gamma-secretase
Source url
s3://convoke-optic-posters/2024-05-10/van-der-Graaf_DeFi-Pain_2023-ASCO_Poster_FINAL.pdf
18 organizations
1 product
Product
NirogacestatOrganization
Netherlands Cancer InstituteOrganization
SpringWorks TherapeuticsOrganization
Dana-Farber Cancer InstituteOrganization
University Hospitals Leuven, Leuven, BelgiumOrganization
University of Colorado Cancer CenterOrganization
University of Michigan Rogel Cancer CenterOrganization
University of HeidelbergOrganization
Memorial Sloan Kettering Cancer CenterOrganization
IQVIAOrganization
McGill University Health CenterOrganization
Harvard Medical SchoolOrganization
KU LeuvenOrganization
Duke University Medical CenterOrganization
Stanford Cancer InstituteOrganization
Oregon Health & Science UniversityOrganization
Mannheim University Medical Center